Newsletter | February 6, 2024

02.06.24 -- Donating Surplus Trial Supplies Is Sustainability's 'Low-Hanging Fruit'

SPONSOR

Cell and gene therapies require advanced logistical considerations to ensure product quality and patient safety. Temperature sensitivity and short shelf lives demand efficient, controlled distribution conditions. Click here to listen to our roundtable panel discussion and learn about the best strategies to anticipate and mitigate disruptions, as well as future innovations and trends that will continue to shape the logistics industry.

FEATURED EDITORIAL

Donating Surplus Trial Supplies Is Sustainability’s ‘Low-Hanging Fruit’

ClinOps professionals know all too well the waste that occurs with leftover trial kits that are destroyed at the end of the trial. Explore donation as a way to give those kits a second life.

INDUSTRY INSIGHTS

Specializing In Small And Early-Stage Partners, Not Just Small Batches

Making a product and meeting a client’s base needs is not enough. Learn why a CDMO should ensure proper care for each client's needs and their timelines and that project progress is a priority.

Direct-To-Patient Supply: Industry Perception And Future Trends

To better understand sponsors’ perspectives on DTP distribution of clinical supplies, 234 individuals involved in clinical supply and operations were recently surveyed. Click here to get the results!

Modern Architecture's Impact On UX In Next-Gen IRT

Explore how interactive response technologies (IRTs) built around microservices models can provide faster initial builds, more rapid change management, and improved built-in test automation.

How Clinical Trial Complexity Impacts End Users

Examine clinical trial complexity through the lens of study investigators, site staff, CRAs, and sponsor study and supply managers and how the RTSM/IRT provides the ability to be as creative as needed.

SOLUTIONS

Cell And Gene Solutions To Power Your Success

Simplify And Optimize Trial Supply Management